Food and Drugs Administration, (FDA) Haryana, India. |
Email ID: dahiya19@yahoo.com
- Key Notes on Revised Schedule M: Point No. 13 – Equipment - December 24, 2024
- Forms: For Homoeopathy Medicines - December 22, 2024
- Key Notes on Revised Schedule M: Point No. 12 – Premises - December 22, 2024
Last Updated on October 2, 2024 by The Health Master
Download Latest Circulars: (IPC) Indian Pharmacopoeia Commission
Download Latest Circulars: (IPC) Indian Pharmacopoeia Commission: Indian Pharmacopoeia Commission (IPC) is an autonomous institution of the Ministry of Health and Family Welfare, Govt. of India. The IPC was created to set standards for drugs in the country.
Its basic function is to regularly update the standards of drugs commonly required for the treatment of diseases prevailing in this region.
It publishes official documents for improving the quality of medicines by way of adding new and updating existing monographs in the form of Indian Pharmacopoeia (IP).
We have provided a list of impurities, a list of reference substances and important notifications, notices and circulars by IPC (Source: IPC website. Click the below links:
List of impurities
For List of Impurities, click the below link:
List of Reference Standards
For List of Reference Standards, click the below link:
List of Phytopharmaceutical Reference Substances
List of Phytopharmaceutical Reference Substances available at IPC Ghaziabad, click below link:
List of IPRS available at IPC, Ghaziabad
List-of-Phtopharmaceutical-Reference-Substances-available-at-IPC-Ghaziabad
Important Notifications / Notices / Circulars by IPC
2024
IPC Alert dt 28-08-2024 Metronidazole Adverse Drug Reactions
2023
IPC dt 02-02-2023 Outcome of Pharmacovigilance Programme of India (PvPI) for taking appropriate regulatory actions
IPC dt 31-01-2023 List of suspected drugs which are associated with the Adverse Drug Reaction
IPC-dt-31-01-2023-List-of-suspected-drugs-which-are-associated-with-the-Adverse-Drug-Reaction
IPC dt 13-01-2023 Amendment list 002 to IP-2022
IPC-dt-13-01-2023-Amendment-list-002-to-IP-2022
2022
IPC dt 13-12-2022 Corrigendum to amendment list 01 of IP 2022
IPC-dt-13-12-2022-Corringedum-to-amendment-list-01-of-IP-2022
IPC dt 28-11-2022 Amendment List 01 to IP 2022
IPC-dt-28-11-2022-Amendment-List-01-to-IP-2022
IPC Notice dt 27-10-2022 Clarifies on uniformity of dosage units & impurities in IP 2022
IPC-Notice-dt-27-10-2022-Clarifies-on-uniformity-of-dosage-units-impurities-in-IP-2022
IPC dt 26-10-2022 Draft Amendments for comments IP 2022
IPC-dt-26-10-2022-Draft-Amendments-for-comments-IP-2022
2021
IPC dt 30-12-2021 – Amendment List-09 to IP-2018
IPC-dt-30-12-2021-Amendment-List-09-to-IP-2018
IPC dt 16-09-2021 – Guidance document on Calibration of Gas Chromatograph
IPC-dt-16-09-2021-Guidance-document-on-Calibration-of-Gas-Chromatograph
IPC dt 16-09-2021 – Guidance document on Calibration of HPLC
IPC-dt-16-09-2021-Guidance-document-on-Calibration-of-HPLC
IPC dt 16-09-2021 – Guidance document on Compliance with Indian Pharmacopoeia Standards
IPC-dt-16-09-2021-Guidance-document-on-Compliance-with-Indian-Pharmacopoeia-Standards
IPC dt 16-09-2021 – Guidance document on Good Documentation Practices
IPC-dt-16-09-2021-Guidance-document-on-Good-Documentation-Practices
IPC dt 16-09-2021 – Guidance document on Legal Status of Indian Pharmacopoeia
IPC-dt-16-09-2021-Guidance-document-on-Legal-Status-of-Indian-Pharmacopoeia
IPC dt 16-09-2021 – Guidance document on Process for Development of Indian Pharmacopoeia Monographs
IPC-dt-16-09-2021-Guidance-document-on-Process-for-Development-of-Indian-Pharmacopoeia-Monographs
IPC dt 16-09-2021 – Guidance document on Quality Management System in Testing Laboratory
IPC-dt-16-09-2021-Guidance-document-on-Quality-Management-System-in-Testing-Laboratory
IPC dt 16-09-2021 – Guidance document on Validation of Analytical Methods
IPC-dt-16-09-2021-Guidance-document-on-Validation-of-Analytical-Methods
IPC Notice dt 26-07-2021 – IP Addendum 2021 shall be effective from 31-12-2021
IPC-Notice-dt-26-07-2021-IP-Addendum-2021-shall-be-effective-from-31-12-2021
IPC dt 24-06-21 – Revised Draft General Chapter on Approach to Alternative Microbiological Methods
IPC-dt-24-06-21-Revised-Draft-General-Chapter-on-Approach-to-Alternative-Microbiological-Methods
IPC 10-03-2021 – Omission of Monographs of ‘Lorcaserin Hydrochloride Hemihydrate’ and Lorcaserin Tablets’ from the Indian Pharmacopoeia
IPC dt 26-02-2021 – Clarification on Alternative Methods in the Indian Pharmacopoeia
IPC-dt-26-02-2021-Clarification-on-Alternative-Methods-in-the-Indian-Pharmacopoeia
IPC dt 25-02-2021 – Amendment List-08 to IP-2018
IPC-dt-25-02-2021-Amendment-List-08-to-IP-2018
IPC 19-02-2021 – Release of Guidance Document for Drafting and Formatting of Monographs for Indian Pharmacopoeia
IPC dt 12-01-2021 – Draft of General Notices on Phytopharmaceutical Drugs
IPC-dt-12-01-2021-Draft-of-General-Notices-on-Phytopharmaceutical-Drugs
Guidance documents by IPC
IPC dt 16-09-2021 – Guidance document on Calibration of Gas Chromatograph
IPC-dt-16-09-2021-Guidance-document-on-Calibration-of-Gas-Chromatograph
IPC dt 16-09-2021 – Guidance document on Calibration of HPLC
IPC-dt-16-09-2021-Guidance-document-on-Calibration-of-HPLC
IPC dt 16-09-2021 – Guidance document on Compliance with Indian Pharmacopoeia Standards
IPC-dt-16-09-2021-Guidance-document-on-Compliance-with-Indian-Pharmacopoeia-Standards
IPC dt 16-09-2021 – Guidance document on Good Documentation Practices
IPC-dt-16-09-2021-Guidance-document-on-Good-Documentation-Practices
IPC dt 16-09-2021 – Guidance document on Legal Status of Indian Pharmacopoeia
IPC-dt-16-09-2021-Guidance-document-on-Legal-Status-of-Indian-Pharmacopoeia
IPC dt 16-09-2021 – Guidance document on Process for Development of Indian Pharmacopoeia Monographs
IPC-dt-16-09-2021-Guidance-document-on-Process-for-Development-of-Indian-Pharmacopoeia-Monographs
IPC dt 16-09-2021 – Guidance document on Quality Management System in Testing Laboratory
IPC-dt-16-09-2021-Guidance-document-on-Quality-Management-System-in-Testing-Laboratory
IPC dt 16-09-2021 – Guidance document on Validation of Analytical Methods
IPC-dt-16-09-2021-Guidance-document-on-Validation-of-Analytical-Methods
IPC Alerts
Click the below links to read full details:
IPC flags drug safety alert against Minoxidil
IPC alert: About Norfloxacin induced skin hyperpigmentation
IPC alerts about Cefoperazone induced coagulopathy
IPC flags safety alert against immunosuppressive drug Tacrolimus
IPC flags safety alert against Blood Pressure drug, Losartan
IPC flags safety alert against most common Drug Ibuprofen – NSAID
IPC flags safety alert against Covid-19 drug Remdesivir
IPC flags safety alert against NSAID Diclofenac
IPC flags safety alert against Dimethyl Fumarate & Cefazolin
Safety alert against Hepatitis C drug Sofosbuvir: IPC
IPC flags Safety Alerts against these drugs interaction
IPC sounds safety alerts against these Medicines
National Indian Pharmacopoeia (IP) 2022
Indian Pharmacopoeia 2022 salient features, click the link below:
Indian-Pharmacopoeia-2022-salient-features
For other Notifications / Notices / Circulars by IPC, Click here
Online purchase: procedure
Books: IP and NFI
IP Reference Substances
Impurity Standards
Latest Circulars, Notices & Guidelines: CDSCO, DCGI
Latest Circulars by ICMR on Pharmaceuticals
Latest Circulars by the Govt of India, Dept of Pharmaceuticals, Health Ministry
Latest Circulars: (IPC) Indian Pharmacopoeia Commission
Compiled by:
Rakesh Dahiya, SDCO cum Licensing Authority, FDA Haryana
For more Notifications on following topics, click below links:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
